CELL AND GENE THERAPY MANUFACTURING
Overcoming Capacity Constraints
How can CGT biotechs overcome issues such as building an in house facility and ultimately get their therapies to patients.
Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA
In this webinar, we discuss pDNA purification, including how to identify optimal conditions for various chromatography media and optimize recovery and impurity removal.
What's New for 2024: Dr. Nicole Verdun Offers a Look Inside The Office Of Therapeutic Products
What is the Office of Therapeutic Products, where did it originate, and what's on its regulatory agenda for 2024?
Tackling Residual DNA Testing In Biotherapy Manufacturing
Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.
Ensure Consistency Across Batches With A Powerful Tool
Learn how to streamline bioprocess control with an innovative software's Unit Save and Load feature. Save configurations, reduce setup time, and ensure consistency across batches with this powerful tool.
What Is The DynaChrom™ Single-Use Chromatography System?
This chromatography system offers a flexible solution, paired with an advanced software platform, allowing easy integration with downstream process automation.
Nunc Standard Closed Cell Factory System
This clean and closed system is designed to provide consistent and high-quality results to enhance your adherent cell culture processes. This ready-to-use system will help you quickly develop and scale up your processes with standard components for supply assurance.
CTS DynaCellect Cinematic Overview
Achieve high cell purity and recovery with an automated, closed magnetic separation system. Learn how this technology helps increase robustness, minimize failures, and streamline cell therapy manufacturing.
Enhancing AAV Purification In Gene Therapy Manufacturing
Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.
Innovative Strategies For Residual DNA And Viral Titre Quantitation
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
2024 Regulatory Outlook With Dr. Peter Marks And Dr. Nicole Verdun | Audience Q&A
Experts on the Cell & Gene Live event, 2024 Regulatory Outlook, answer questions about topics including pediatric development in rare diseases, diversity planning for ultra-rare disease, anticipated approvals by 2025, and more.
Scalable Purification Of In Vitro Transcribed mRNA
Learn more about how affinity-based mRNA chromatography resin facilitates the purification and isolation of mRNA from in vitro transcription (IVT) manufacturing processes.
Master The 2-Point Calibration Process To Maintain Data Integrity
Ensure accurate sensor readings with an innovative software by mastering the 2-point calibration process. Learn more about how and why regular calibration supports data integrity and compliance.
Defining The CMC / Clinical Relationship For Allogeneic Cell Therapies
During this segment, Nguyen and Wagner define why the relationship between CMC and Clinical is so critical, and they also explain what a mutually beneficial partnership between CMC and Clinical looks like.
Inside Bioprocessing: Continuous Perfusion
Learn about the essential elements of upstream workflows, media optimization strategies, and liquid handling logistics required to implement continuous perfusion successfully.
Knowledge Culture Basics — Gene Therapy Education Series: Lentiviral Vectors
In this session of our ongoing education series on lentiviral vectors, we delve further into principles of lentiviral transduction and challenges in suspension-based lentivirus production.
Genentech, Myeloid's Approaches To mRNA Technologies
Experts at a Cell & Gene Live event discussed the use of mRNA technology in cancer immunotherapy, including a brief overview of the different approaches being used to leverage mRNA technology.
Supporting Development Of mRNA Therapeutics By Enabling Commercial-Scale mRNA Purification
Discover the next generation of scalable affinity capture for high-quality mRNA purification. Learn how a simple, reliable binding mechanism can maximize efficiency and simplify your manufacturing process.
Dr. Peter Marks Talks a Standardized Playbook for Gene Therapy Manufacturing
In this segment, Dr. Peter Marks shares developments in CMC for advanced therapies in the near future.
Enhanced Chromatography Resins For Faster, More Efficient Purification
Learn from an industry veteran about the evolution of protein purification, from early equipment to modern, agile solutions, emphasizing continuous improvement and customer-centric approaches.
Accelerating Process Scale-Up From Benchtop To Commercialization- From Controller To Software
Discover strategies for optimizing process control, refining media selection, and ensuring safety through rigorous contaminant detection to mitigate development risks.
CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy
Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030.
A Robust, Future-Ready Solution That Adapts To Your Needs
Explore a future-ready solution that features advanced automation, intuitive design, and scalable solutions to streamline your bioprocessing workflows and prepare your operations for future growth.
Advancing The Purification Of VSV-G Pseudotyped Lentiviral Vector
Discover new strategies to overcome lentiviral purification challenges with a scalable approach that maintains viral infectivity through gentle processing conditions.
Rapid Process Development And Technical Support For AAV Scaleup
Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.
CTS OpTmizer One SFM: Thoughtfully Designed Nutrition For T Cells
Learn about a novel, next-generation medium with an animal-component-free formulation developed to support the need for a T-cell medium that allows consistent, reproducible, and automated T-cell manufacturing.
Perfusion: Hardware Needs
In this video, we will discuss cell retention mechanisms, pumps, and intensification challenges in the perfusion process.
CaptureSelect Affinity Chromatography
30-second video sharing a visualization of our CaptureSelect affinity chromatography capability. The target protein binds with VHH molecules immobilized on the chromatography beads, non-target proteins are removed, and the eluted fraction contains a high yield of pur...
Maximize Quality Assurance Through Rapid Sterility Testing
This webinar explores mitigating the risk of product loss, and production delays, as well as the critical role rapid sterility testing plays in ensuring the quality and safety of cell therapy products.
How Past Gene Therapy Approvals Are Shaping the Future with Dr. Peter Marks
In this segment of Cell & Gene Live, Dr. Peter Marks shared what he and his team have learned from current gene therapy approvals to accelerate future approvals.